Bethlehem, PA, USA, September 21, 2021 – ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today introduced large-scale single-use Tangential Flow Filtration (TFF) systems. With the industry’s largest flow rates and filter areas, ABEC’s CSR TFF technology enables the highest TFF productivity available in a single-use format. The CSR TFF achieves […]
Tag: <span>2021</span>
BIOVECTRA Enhances Manufacturing Capacity and Flexibility with ABEC’s CSR® Large-Scale, Single-Use Microbial Fermentation Technology
Bethlehem, PA, USA, and Charlottetown, CANADA, September 20, 2021 – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing and BIOVECTRA, a CDMO specializing in clinical-to-commercial scale production of high-quality regulated Biologics, Active Pharmaceutical Ingredients, and intermediates, today announced ABEC will design, manufacture, and install CSR single-use microbial fermentation solutions at BIOVECTRA’s […]
HEC Pharm Selects ABEC Large-Scale Fermenters to Increase Biopharmaceutical Production Capacity
Bethlehem, PA, USA, April 12, 2021 – ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced it will design, manufacture, and install multiple 4,000L fermenter trains for HEC Pharm’s manufacturing site in Guangzhou, China. The stainless-steel fermenter trains are custom designed to support HEC Pharm’s scale-up initiative of their advanced insulin products. HEC […]
ABEC CSR® Single-Use Fermenters to Support Catalent Cell & Gene Therapy Manufacturing Expansion
Bethlehem, PA, USA, April 6, 2021 – ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that it has supplied two 50L CSR single-use fermenters to Catalent Cell & Gene Therapy. The custom designed systems were delivered on an accelerated schedule to meet Catalent’s specific process requirements and address the […]
mAbxience Expanding Biosimilar and CDMO Manufacturing Capacity with ABEC 4,000 Liter Single-Use Bioreactor
Bethlehem, PA, USA, March 23, 2021, ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L CSR Bioreactor. The system will be commissioned mid-2021 and will significantly increase biosimilar and CDMO manufacturing capacity at the León site. mAbxience […]